NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

CD86 confers and directs and MHC class I restricted CTL induction.

Agadjanyan M, Kim J, Weiner D; International Conference on AIDS.

Int Conf AIDS. 1998; 12: 277 (abstract no. 21195).

University of Pennsylvania, Philadelphia, USA.

DNA plasmid based immunization has emerged recently as a promising novel vaccine strategy and our laboratory has been investigating the potential of this technique for the development of a vaccine against HIV since 1993. Muscle tissue has previously been demonstrated to be a major site of antigen expression after intramuscular injection of DNA vaccines. Unlike professional antigen presenting cells (APCs), however, muscle cells do not express the costimulatory molecules CD80 (B7-1) or CD86 (B7-2) which provide critical secondary signals for T-cell activation. Recently we the first time presented data demonstrating that co-inoculation of mice with DNA plasmids encoding HIV-1 antigens with genes for CD86 dramatically increased antigen-specific T-cell responses without a significant change in humoral immune response. To resolve whether muscle cells or professional APCs are responsible for enhancement of anti-viral CTL following CD86 co-inoculation, we constructed a set of bone marrow chimeric animals using mice bearing a genetic disruption of beta 2-microglobulin (beta 2 m). The relationship between CTL induction and MHC class I-restriction after expression of both viral antigen and CD80 or CD86 costimulatory molecule genes was determined. MHC class I-restriction of CTL was determined to be under the providence of the B7-2 (CD86) molecule, even when this molecule and antigen were displayed on a non-professional antigen presenting cell background. This study defines a role of CD86 in CTL immune induction during DNA immunization. Our results demonstrated that non-hematopoeitic cells, most likely muscle cells, can be engineered to present the viral antigen.

Publication Types:
  • Meeting Abstracts
Keywords:
  • AIDS Vaccines
  • Animals
  • Antigen-Presenting Cells
  • Antigens, CD
  • Antigens, CD80
  • Antigens, Viral
  • CD86 protein, human
  • Genes, MHC Class I
  • Lymphocyte Activation
  • Membrane Glycoproteins
  • Mice
  • Resin Cements
  • T-Lymphocytes, Cytotoxic
  • Vaccines, DNA
  • beta 2-Microglobulin
  • genetics
  • immunology
Other ID:
  • 98393926
UI: 102228734

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov